Dr. Joyson Poulose
Claim this profileGuthrie Medical Group PC-Robert Packer Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
26 reported clinical trials
67 drugs studied
About Joyson Poulose
Education:
- Earned an Associate in Applied Science (A.A.S.) degree in Respiratory Therapy from Guthrie Robert Packer Hospital, Sayre, PA.
Experience:
- Serves as a Clinical Instructor in Respiratory Therapy at Guthrie Robert Packer Hospital, Sayre, PA.
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR negative
2Non-Small Cell Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Joyson Poulose is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
More about Joyson Poulose
Clinical Trial Related5 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Joyson Poulose has experience with
- Pembrolizumab
- Fluorouracil
- Nivolumab
- Carboplatin
- Biospecimen Collection
- Leucovorin Calcium
Breakdown of trials Joyson Poulose has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joyson Poulose specialize in?
Joyson Poulose focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Joyson Poulose currently recruiting for clinical trials?
Yes, Joyson Poulose is currently recruiting for 14 clinical trials in Sayre Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Joyson Poulose has studied deeply?
Yes, Joyson Poulose has studied treatments such as Pembrolizumab, Fluorouracil, Nivolumab.
What is the best way to schedule an appointment with Joyson Poulose?
Apply for one of the trials that Joyson Poulose is conducting.
What is the office address of Joyson Poulose?
The office of Joyson Poulose is located at: Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania 18840 United States. This is the address for their practice at the Guthrie Medical Group PC-Robert Packer Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.